Moneycontrol PRO
HomeNewsBusinessMarket Update: Aurobindo Pharma, BPCL, IOC gain 2% each; Phoenix Mills jumps 4%, Dish TV hits 52-week low

Market Update: Aurobindo Pharma, BPCL, IOC gain 2% each; Phoenix Mills jumps 4%, Dish TV hits 52-week low

The market breadth was in favour of the advances with 878 stocks advancing while 789 declined and 348 remained unchanged. On the other hand, in the BSE, 1268 stocks advanced and 1260 declined and 160 remained unchanged.

March 06, 2018 / 13:37 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    The Indian benchmark indices were trading on a positive note on Tuesday afternoon with the Nifty gaining 37 points at 10,396 while the Sensex was up 79 points.

    The Nifty metal Index was the outperforming sector which jumped close to 1 percent led by Jindal Steel & Power, Vedanta, NMDC, JSW Steel and Tata Steel and Welspun Corp among others.

    Nifty Realty was also trading in the green led by Phoenix MillsOberoi Realty and DLF.

    The banking index was also trading in the green led by IndusInd Bank and Yes Bank, each adding over 1 percent.

    From the Nifty the stocks which gained the most were Zee Entertainment, Indiabulls Housing, Aurobindo Pharma, BPCL and IOC.

    The most active Nifty stocks included IDBI Bank, Reliance Industries, Sun Pharma, Axis Bank and Tata Steel.

    The other top losers included Bharti Infratel, Mahindra & Mahindra, Lupin, Bosch and Sun Pharma.

    The top Sensex gainers were Vakrangee which jumped 5 percent followed by PC Jeweller, IDBI, BF Utilities and Bombay Dyeing.

    Firstsource Solutions and Phoenix Mills were few of the stocks that hit fresh 52-week high while Balrampur Chini, Gitanjali Gems, Canara Bank and Dish TV were the stocks which hit new 52-week low.

    The market breadth was in favour of the advances with 878 stocks advancing while 789 declined and 348 remained unchanged. On the other hand, in the BSE, 1268 stocks advanced and 1260 declined and 160 remained unchanged.

    Global research house Credit Suisse has come out with a report on pharma major Sun Pharmaceutical Industries wherein the house feels that the Halol facility observations require remediation, but likely no re-inspection.

    The firm expects the company to get clearance for the Halol plant in the next 4-6 months adding that the US FDA observations are not very serious. It is of the view that observations 2 and 3 are procedural in nature while observation 1 relates to aseptic processing of drug products.

    Disclaimer: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd

     

    Sandip Das
    first published: Mar 6, 2018 10:02 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
    CloseOutskill Genai